Frederick C. Kull

Department of Molecular Sciences, Glaxo Wellcome, Inc., Five Moore Drive, Research Triangle Park, NC 27709, USA

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers24 papers

Sort

By YearBy Citation

Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580

James G. Conway,Brad McDonald,Janet Parham,Barry Keith,David W. Rusnak,Eva Shaw,Marilyn Jansen, Peiyuan Lin,Alan Payne,Renae M. Crosby,Jennifer H. Johnson,Lloyd Frick

Proceedings of the National Academy of Sciences of the United States of America, no. 44 (2005): 16078-16083

Cited by167WOSBibtex

A cell-based time-resolved fluorescence assay for selection of antibody reagents for G protein-coupled receptor immunohistochemistry

Jui-Lan Su,Jim Fornwald,Philip Rivers,Susan Goldsworthy,Noeleen A Looney,Jeff Hanvey,Chris Plumpton,Janet Parham,Michael Romanos,Thomas A Kost,Frederick C Kull

Journal of Immunological Methods, no. 1 (2004): 123-135

Cited by10WOSEIBibtex

Production and characterization of monoclonal antibodies against the vasoconstrictive peptide human urotensin-II

Jui-Lan Su,Zhaohui Ao,Nambi V Aiyar,Byron Ellis,John D Martin,Stephen A Douglas,Frederick C Kull

Hybridoma and hybridomics, no. 6 (2003): 377-382

Cited by4WOSBibtex

Site-specific Conjugation on Serine → Cysteine Variant Monoclonal Antibodies

Julie B Stimmel,Barbara M Merrill,Lee F Kuyper,Cary P Moxham,Jeff T Hutchins,M E Fling,Frederick C Kull

Journal of Biological Chemistry, (2000)

Cited by57Bibtex

Development of class-switched, affinity-matured monoclonal antibodies following a 7-day immunization schedule

J Bynum,J L Andrews,B Ellis,F C Kull,E A Austin,K E Kilpatrick

Hybridoma, no. 5 (1999): 407-411

Cited by15WOSBibtex

Samarium-153 and Lutetium-177 Chelation Properties of Selected Macrocyclic and Acyclic Ligands

Julie B Stimmel,Frederick C Kull

Nuclear Medicine and Biology, no. 2 (1998): 117-125

Cited by62EIWOSBibtex

Yttrium-90 chelation properties of tetraazatetraacetic acid macrocycles, diethylenetriaminepentaacetic acid analogs, and a novel terpyridine acyclic chelator. [Erratum to document cited in CA122:182159]

Julie B. Stimmel,Marie E. Stockstill,Frederick C. Kull

BIOCONJUGATE CHEMISTRY, no. 4 (1995): 506-506

Bibtex

Generation of murine monoclonal antihuman milk fat globule membrane antibodies using immunoprecipitation and BIAcore analyses

J Bynum,J T Hutchins,F C Kull

Hybridoma, no. 6 (1995): 587-591

WOSBibtex

Potent gastrin-releasing peptide (GRP) antagonists derived from GRP (19-27) with a C-terminal DPro psi [CH2NH]Phe-NH2 and N-terminal aromatic residues

J J Leban,A Landavazo,J D McDermed,E J Diliberto,M Jansen,B Stockstill,F C Kull

Journal of medicinal chemistry, no. 4 (1994): 439-445

Cited by2WOSBibtex

YTTRIUM-90 CHELATION PROPERTIES OF TETRAAZA TETRAACETIC ACID MACROCYCLES AND DIETHYLENE-TRIAMINEPENTAACETIC ANALOGUE CHELATORS:

J. B. Stimmel,F. C. Kull

Journal of Immunotherapy, no. 2 (1994)

Bibtex

A novel bombesin receptor antagonist (2258U89), potently inhibits bombesin evoked release of gastrointestinal hormones from rats and dogs, in vitro and in vivo

P Singh,Y S Guo,F C Kull,J J Leban

Regulatory peptides, no. 1 (1992): 75-86

Cited by16WOSEIBibtex

Tumoricidal effector mechanisms of murine BCG-activated macrophages: role of TNF in conjugation-dependent and conjugation-independent pathways

J Klostergaard,P A Stoltje,F C Kull

Journal of leukocyte biology, no. 3 (1990): 220-228

Cited by16WOSBibtex

Drug-induced alterations of tumor necrosis factor-mediated cytotoxicity: discrimination of early versus late stage action

F C Kull,J M Besterman

Journal of cellular biochemistry, no. 1 (1990): 1-12

Cited by15WOSBibtex

Tumoricidal Effector Mechanisms of Murine BCG‐Activated Macrophages: Role of TNF in Conjugation‐Dependent and Conjugation‐Independent Pathways

Jim Klostergaard, Paul A. Stoltje,Frederick C. Kull

Journal of Leukocyte Biology, no. 3 (1990): 220-228

Bibtex

The effect of nicotinamide on microvascular density and thermal injury in rats

Yale R. Smith,Bruce Klitzman,M. Nixon Ellis,Frederick C. Kull

The Journal of surgical research, no. 5 (1989): 465-469

Cited by16EIWOSBibtex

Reduction in tumor necrosis factor receptor affinity and cytotoxicity by glucocorticoids

Frederick C. Kull

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, no. 1 (1988): 402-409

Cited by39EIWOSBibtex

An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture

Quynh T. Rohlik,David Adams,Frederick C. Kull,Steven Jacobs

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, no. 1 (1987): 276-281

Cited by109EIWOSBibtex

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity

Frederick C Kull,Jacobs S,Cuatrecasas P

Proceedings of the National Academy of Sciences of the United States of America, no. 17 (1985): 5756-5760

Cited by187WOSBibtex

Monoclonal Antibodies as Probes for Insulin and Insulin-like Growth Factor-I Receptors

Steven Jacobs,Frederick C Kull,Pedro Cuatrecasas

(1984)

Bibtex

Method of promoting healing

Frederick C Kull, Frank A Voelker

(1984)

Cited by61Bibtex

View All

Base Info Papers Patents Projects